Skip to main content
OpenTrials
Completed

NCT Number: NCT00468741

Component and Couple Analysis of Cancer Communications

Component and Couple Analysis of Cancer Communication

CHESS, the Comprehensive Health Enhancement Support System is an innovative technology that provides information, social support and skills training to women with breast cancer. Previous CHESS clinical trials found improved patient outcomes but little is known about what services in CHESS produce those results. This study will examine whether breast cancer patient outcomes change when conceptually distinct CHESS services (information, social support, and skills training) are systematically added to a patients treatment resources.

Primary Aims:

* Determine the relative efficacies of different types of cancer communication treatments when they are presented alone or in combination * Determine routes or processes via which these elements work * Determine for whom the different treatment types work best.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Hartford Hospital, Hartford, Connecticut, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Eligibility for this protocol is as follows:

  • All subjects must be within 2 months of their primary breast cancer diagnosis,
  • All subjects must be at least 18 years of age,
  • All subjects must be able to read and write English at the 6th-grade level
  • Not homeless

Treatment and study plan

CHESS (Comprehensive Health Enhancement Support System)

Behavioral

Full CHESS for subject use

CHESS

Behavioral

informational services of CHESS available to subject

Primary outcomes

  1. Patient Quality of Life

    Time frame: monthly

Secondary outcomes

  1. Emotional Well-being

    Time frame: monthly

  2. Self Efficacy

    Time frame: monthly

Sponsors and collaborators

Lead sponsor

University of Wisconsin, Madison

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2003
Primary completion
2008
Study completion
2014
First posted
May 3, 2007
Registry last updated
Nov 18, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.